Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_assertion type Assertion NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_head.
- NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_assertion description "[This raises the question as to whether there is a subset of patients with skin cancer or AK lesions that are highly/more susceptible to local reactions caused by cyclo-oxygenase-2 (COX-2) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_provenance.
- NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_assertion evidence source_evidence_literature NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_provenance.
- NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_assertion SIO_000772 17488409 NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_provenance.
- NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_assertion wasDerivedFrom befree-2016 NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_provenance.
- NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_assertion wasGeneratedBy ECO_0000203 NP608979.RA0NVOU7i_oe2o-Rq3tMdVnB0MjfOncmxdKox4NpQoAXs130_provenance.